5 Item 1A. Risk Factors 62 Item 1B. Unresolved Staff Comments 104 Item 1C. Cybersecurity 104 Item 2. Properties 105 Item 3. Legal Proceedings 105 Item 4. Mine Safety Disclosures 106 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 107 Item 6. [Reserved] 107 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 108 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001818382-26-000004 | EDGAR | 121K words |
| 2025-03-31 | 2024-12-31 | 0001818382-25-000034 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001818382-24-000040 | EDGAR | — |
| 2023-03-24 | 2022-12-31 | 0001818382-23-000016 | EDGAR | — |
| 2022-03-29 | 2021-12-31 | 0001818382-22-000011 | EDGAR | — |
| 2021-02-16 | 2020-12-31 | 0001213900-21-009571 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001818382-25-000132 | EDGAR | 37K words |
| 2025-08-11 | 2025-06-30 | 0001818382-25-000125 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001818382-25-000076 | EDGAR | — |
| 2024-11-08 | 2024-09-30 | 0001818382-24-000199 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001818382-24-000156 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001818382-24-000056 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001818382-23-000162 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001818382-23-000114 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001818382-23-000030 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001818382-22-000180 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001818382-22-000105 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001818382-22-000039 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-19 | 0001104659-26-032116 | EDGAR | 17K words |
| 2026-03-19 | 0001104659-26-031780 | EDGAR | — |
| 2025-12-16 | 0001104659-25-121674 | EDGAR | — |
| 2025-12-15 | 0001104659-25-121214 | EDGAR | — |
| 2025-12-15 | 0001104659-25-120915 | EDGAR | — |
| 2025-11-26 | 0001104659-25-116476 | EDGAR | — |
| 2025-11-12 | 0001104659-25-109718 | EDGAR | — |
| 2025-10-07 | 0001104659-25-097591 | EDGAR | — |
| 2025-09-18 | 0001104659-25-090963 | EDGAR | — |
| 2025-08-11 | 0001818382-25-000122 | EDGAR | — |
111 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001818382 |
| Ticker | HUMA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.humacyte.com |
| Listed | 2021-08-27 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report